Siddhartha Sankar Jana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Siddhartha Sankar Jana has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Shekhar Saha
University of Virginia 2 Department of Biochemistry and Molecular Genetics Charlottesville, Virginia
9 shared publications Ditipriya Mallick
School of Biological Sciences, Indian Association for the Cultivation of Science, Kolkata, India
8 shared publications- Sumit Kumar Dey
School of Biological Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata 700032, India
6 shared publications - Pabitra Pal Choudhury
Applied Statistics Unit, Indian Statistical Institute, Kolkata 700108, West Bengal, India
5 shared publications Debdatta Halder
School of Biological Sciences, Indian Association for the Cultivation of Science, Kolkata, India; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel(2)
4 shared publicationsIndranil Ghosh
Indian Association for the Cultivation of Science 1 School of Biological Sciences , Kolkata 700032
4 shared publications
Latest Publications
- Open Access
- 9 April 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (6) , 111443
Binding of RbFox proteins at weak 5’splice site of A2 induces its alternative splicing in non-muscle myosin heavy-chain IIA mRNA
- 9 April 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (6) , 111443
Open AccessBinding of RbFox proteins at weak 5’splice site of A2 induces its alternative splicing in non-muscle myosin heavy-chain IIA mRNA
- 1 November 2025
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 138 (21)
Cellular elasticity drives mechano-adaptation against fluid shear stress
Cancer cells adapt to external biophysical cues, but how cytoskeletal remodeling facilitates this mechano-adaptation is largely unexplored. Here, we demonstrate that intrinsic non-muscle myosin II (NMII) activity and self-organization in cancer cells regulate cellular elastic properties when cells are exposed to fluid shear stress (FSS). In association with the reorganized actin filament network, NMII bipolar filaments can assemble into aligned stacks, which allow cellular stretching upon exposure to FSS. Inhibition of NMII by treatment with small interfering RNA, (−)blebbistatin or Y27632 impairs the stack formation and perturbs cellular elasticity. Moreover, NMII-mediated elasticity regulates cyto-nuclear coupling through its association with the LINC complex protein nesprin2 and regulates nuclear import of the mechanoresponsive proteins YAP1 and TAZ (also known as WWTR1), which induce differential expression of genes thus decreasing growth and migration in FSS-exposed cells. These findings reveal that the cellular elasticity mediated by NMII dynamics provides mechano-adaptation against a mechanical stress, like FSS.
- 1 November 2025
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 138 (21)
Cellular elasticity drives mechano-adaptation against fluid shear stress
Cancer cells adapt to external biophysical cues, but how cytoskeletal remodeling facilitates this mechano-adaptation is largely unexplored. Here, we demonstrate that intrinsic non-muscle myosin II (NMII) activity and self-organization in cancer cells regulate cellular elastic properties when cells are exposed to fluid shear stress (FSS). In association with the reorganized actin filament network, NMII bipolar filaments can assemble into aligned stacks, which allow cellular stretching upon exposure to FSS. Inhibition of NMII by treatment with small interfering RNA, (−)blebbistatin or Y27632 impairs the stack formation and perturbs cellular elasticity. Moreover, NMII-mediated elasticity regulates cyto-nuclear coupling through its association with the LINC complex protein nesprin2 and regulates nuclear import of the mechanoresponsive proteins YAP1 and TAZ (also known as WWTR1), which induce differential expression of genes thus decreasing growth and migration in FSS-exposed cells. These findings reveal that the cellular elasticity mediated by NMII dynamics provides mechano-adaptation against a mechanical stress, like FSS.
- Open Access
Expression of nonmuscle myosin IIC is regulated by non-canonical binding activity of miRNAs
- Open Access
- 8 August 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (9) , 105143
A brain specific alternatively spliced isoform of nonmuscle myosin IIA lacks its mechanoenzymatic activities
- 8 August 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (9) , 105143
Open AccessA brain specific alternatively spliced isoform of nonmuscle myosin IIA lacks its mechanoenzymatic activities
- 13 April 2023
- Published by Elsevier in Gene Reports
- Vol. 31, 101771
Investigation of codon alternation patterns in two neurodegenerative diseases through numerical representation and codon classification
- 13 April 2023
- Published by Elsevier in Gene Reports
- Vol. 31, 101771
Investigation of codon alternation patterns in two neurodegenerative diseases through numerical representation and codon classification
- Open Access
- 13 February 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (2) , 112108
Assembly and disassembly dynamics of nonmuscle myosin II control endosomal fission
- 13 February 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (2) , 112108
Open AccessAssembly and disassembly dynamics of nonmuscle myosin II control endosomal fission
- Open Access
- 31 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 20, 766-778
D155Y substitution of SARS-CoV-2 ORF3a weakens binding with Caveolin-1
The clinical manifestation of the recent pandemic COVID-19, caused by the novel SARS-CoV-2 virus, varies from mild to severe respiratory illness. Although environmental, demographic and co-morbidity factors have an impact on the severity of the disease, contribution of the mutations in each of the viral genes towards the degree of severity needs a deeper understanding for designing a better therapeutic approach against COVID-19. Open Reading Frame-3a (ORF3a) protein has been found to be mutated at several positions. In this work, we have studied the effect of one of the most frequently occurring mutants, D155Y of ORF3a protein, found in Indian COVID-19 patients. Using computational simulations we demonstrated that the substitution at 155th changed the amino acids involved in salt bridge formation, hydrogen-bond occupancy, interactome clusters, and the stability of the protein compared with the other substitutions found in Indian patients. Protein–protein docking using HADDOCK analysis revealed that substitution D155Y weakened the binding affinity of ORF3a with caveolin-1 compared with the other substitutions, suggesting its importance in the overall stability of ORF3a-caveolin-1 complex, which may modulate the virulence property of SARS-CoV-2.
- 31 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 20, 766-778
Open AccessD155Y substitution of SARS-CoV-2 ORF3a weakens binding with Caveolin-1
The clinical manifestation of the recent pandemic COVID-19, caused by the novel SARS-CoV-2 virus, varies from mild to severe respiratory illness. Although environmental, demographic and co-morbidity factors have an impact on the severity of the disease, contribution of the mutations in each of the viral genes towards the degree of severity needs a deeper understanding for designing a better therapeutic approach against COVID-19. Open Reading Frame-3a (ORF3a) protein has been found to be mutated at several positions. In this work, we have studied the effect of one of the most frequently occurring mutants, D155Y of ORF3a protein, found in Indian COVID-19 patients. Using computational simulations we demonstrated that the substitution at 155th changed the amino acids involved in salt bridge formation, hydrogen-bond occupancy, interactome clusters, and the stability of the protein compared with the other substitutions found in Indian patients. Protein–protein docking using HADDOCK analysis revealed that substitution D155Y weakened the binding affinity of ORF3a with caveolin-1 compared with the other substitutions, suggesting its importance in the overall stability of ORF3a-caveolin-1 complex, which may modulate the virulence property of SARS-CoV-2.
- 1 October 2021
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 139, 106058
Nonmuscle Myosin II in cancer cell migration and mechanotransduction
- 1 October 2021
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 139, 106058
Nonmuscle Myosin II in cancer cell migration and mechanotransduction
- Open Access
D155Y Substitution of SARS-CoV-2 ORF3a Weakens Binding with Caveolin-1
The clinical manifestation of the recent pandemic COVID-19, caused by novel SARS-CoV-2, varies from mild to severe respiratory illness. Although environmental, demographicand co-morbidity factors have an impact on the severity of the disease, the contribution of mutations in each of the viral genes towards the degree of severity needs to be elucidated for designing better therapeutic approach against COVID-19. Here, we studied the effect of two substitutions D155Y and S171L, of ORF3a protein, found in COVID-19 patients. Using computational simulations we discovered that the substitutions at 155th and 171st positions changed the amino acids involved in salt bridge formation, hydrogen-bond occupancy, interactome clusters, and the stability of the protein. Protein-protein docking using HADDOCK analysis revealed that out of the two observed substitutions, only the substitution of D155Y, weakened the binding affinity of ORF3a with caveolin-1. The increased fluctuation in the simulated ORF3a-caveolin-1 complex suggested a change in the virulence property of SARS-CoV-2. Importance The binding interaction of viral ORF3a protein to host caveolin-1 is essential for entry and endomembrane trafficking of SARS-CoV-2. The D155Y substitution in SARS-CoV-2 ORF3a is located near its caveolin-binding Domain IV and thus the substitution can interfere with the binding affinity of ORF3a to host caveolin-1. Our in silico study report decreased molecular stability of D155Y mutant of ORF3a and increased fluctuation of the simulated D155Y ORF3a-caveolin-1 complex. Thus, we hypothesize that the D155Y substitution could change the virulence property of SARS-CoV-2.
Open AccessD155Y Substitution of SARS-CoV-2 ORF3a Weakens Binding with Caveolin-1
The clinical manifestation of the recent pandemic COVID-19, caused by novel SARS-CoV-2, varies from mild to severe respiratory illness. Although environmental, demographicand co-morbidity factors have an impact on the severity of the disease, the contribution of mutations in each of the viral genes towards the degree of severity needs to be elucidated for designing better therapeutic approach against COVID-19. Here, we studied the effect of two substitutions D155Y and S171L, of ORF3a protein, found in COVID-19 patients. Using computational simulations we discovered that the substitutions at 155th and 171st positions changed the amino acids involved in salt bridge formation, hydrogen-bond occupancy, interactome clusters, and the stability of the protein. Protein-protein docking using HADDOCK analysis revealed that out of the two observed substitutions, only the substitution of D155Y, weakened the binding affinity of ORF3a with caveolin-1. The increased fluctuation in the simulated ORF3a-caveolin-1 complex suggested a change in the virulence property of SARS-CoV-2. Importance The binding interaction of viral ORF3a protein to host caveolin-1 is essential for entry and endomembrane trafficking of SARS-CoV-2. The D155Y substitution in SARS-CoV-2 ORF3a is located near its caveolin-binding Domain IV and thus the substitution can interfere with the binding affinity of ORF3a to host caveolin-1. Our in silico study report decreased molecular stability of D155Y mutant of ORF3a and increased fluctuation of the simulated D155Y ORF3a-caveolin-1 complex. Thus, we hypothesize that the D155Y substitution could change the virulence property of SARS-CoV-2.
- 1 January 2021
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 134 (1)
Switching between blebbing and lamellipodia depends on the degree of non-muscle myosin II activity
Cells can adopt both mesenchymal and amoeboid modes of migration through membrane protrusive activities, namely formation of lamellipodia and blebbing. How the molecular players control the transition between lamellipodia and blebs is yet to be explored. Here, we show that addition of the ROCK inhibitor Y27632 or low doses of blebbistatin, an inhibitor of non-muscle myosin II (NMII) ATPase activity and filament partitioning, induces blebbing to lamellipodia conversion (BLC), whereas addition of low doses of ML7, an inhibitor of myosin light chain kinase (MLCK), induces lamellipodia to blebbing conversion (LBC) in human MDA-MB-231 cells. Similarly, siRNA-mediated knockdown of ROCK and MLCK induces BLC and LBC, respectively. Interestingly, both blebs and lamellipodia membrane protrusions are able to maintain the ratio of phosphorylated to unphosphorylated regulatory light chain at cortices when MLCK and ROCK, respectively, are inhibited either pharmacologically or genetically, suggesting that MLCK and ROCK activities are interlinked in BLC and LBC. Such BLCs and LBCs are also inducible in other cell lines, including MCF7 and MCF10A. These studies reveal that the relative activity of ROCK and MLCK, which controls both the ATPase activity and filament-forming property of NMII, is a determining factor in whether a cell exhibits blebbing or lamellipodia.
- 1 January 2021
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 134 (1)
Switching between blebbing and lamellipodia depends on the degree of non-muscle myosin II activity
Cells can adopt both mesenchymal and amoeboid modes of migration through membrane protrusive activities, namely formation of lamellipodia and blebbing. How the molecular players control the transition between lamellipodia and blebs is yet to be explored. Here, we show that addition of the ROCK inhibitor Y27632 or low doses of blebbistatin, an inhibitor of non-muscle myosin II (NMII) ATPase activity and filament partitioning, induces blebbing to lamellipodia conversion (BLC), whereas addition of low doses of ML7, an inhibitor of myosin light chain kinase (MLCK), induces lamellipodia to blebbing conversion (LBC) in human MDA-MB-231 cells. Similarly, siRNA-mediated knockdown of ROCK and MLCK induces BLC and LBC, respectively. Interestingly, both blebs and lamellipodia membrane protrusions are able to maintain the ratio of phosphorylated to unphosphorylated regulatory light chain at cortices when MLCK and ROCK, respectively, are inhibited either pharmacologically or genetically, suggesting that MLCK and ROCK activities are interlinked in BLC and LBC. Such BLCs and LBCs are also inducible in other cell lines, including MCF7 and MCF10A. These studies reveal that the relative activity of ROCK and MLCK, which controls both the ATPase activity and filament-forming property of NMII, is a determining factor in whether a cell exhibits blebbing or lamellipodia.